Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M195,950Revenue $M51,584Net Margin (%)20.9Z-Score2.7
Enterprise Value $M199,906EPS $3.2Operating Margin %27.0F-Score4
P/E(ttm))19.2Cash Flow Per Share $3.5Pre-tax Margin (%)27.0Higher ROA y-yN
Price/Book2.510-y EBITDA Growth Rate %3.1Quick Ratio2.5Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %9.0Current Ratio2.9Lower Leverage y-yN
Price/Cash Flow7.2y-y EBITDA Growth Rate %2.5ROA % (ttm)6.1Higher Current Ratio y-yN
Dividend Yield %3.3Insider Buy (3m)0ROE % (ttm)13.6Less Shares Outstanding y-yY
Payout Ratio %63.0Shares Outstanding M6,341ROI % (ttm)21.6Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFEIrving Kahn 2014-09-30 Reduce-0.59%$28.04 - $30.96
($29.58)
$ 31.15%Reduce -6.56%1,985,161
PFEMichael Price 2014-09-30 Reduce-0.22%$28.04 - $30.96
($29.58)
$ 31.15%Reduce -56.02%47,100
PFEJean-Marie Eveillard 2014-09-30 Reduce-0.16%$28.04 - $30.96
($29.58)
$ 31.15%Reduce -94.11%135,661
PFERay Dalio 2014-09-30 Reduce-0.02%$28.04 - $30.96
($29.58)
$ 31.15%Reduce -24.91%295,108
PFEHOTCHKIS & WILEY 2014-09-30 Sold Out -0.01%$28.04 - $30.96
($29.58)
$ 31.15%Sold Out0
PFEVanguard Health Care Fund 2014-06-30 Add0.62%$29.02 - $32.4
($30.05)
$ 31.14%Add 105.23%14,934,022
PFEJoel Greenblatt 2014-06-30 Add0.27%$29.02 - $32.4
($30.05)
$ 31.14%Add 71.59%1,741,314
PFECharles Brandes 2014-06-30 Add0.12%$29.02 - $32.4
($30.05)
$ 31.14%Add 5.78%6,075,460
PFERay Dalio 2014-06-30 Add0.06%$29.02 - $32.4
($30.05)
$ 31.14%Add 250.56%393,008
PFEMichael Price 2014-06-30 Reduce-0.97%$29.02 - $32.4
($30.05)
$ 31.14%Reduce -69.14%107,100
PFENWQ Managers 2014-06-30 Reduce-0.81%$29.02 - $32.4
($30.05)
$ 31.14%Reduce -31.07%6,363,006
PFEDodge & Cox 2014-06-30 Reduce-0.5%$29.02 - $32.4
($30.05)
$ 31.14%Reduce -23.73%48,902,097
PFEJean-Marie Eveillard 2014-06-30 Reduce-0.47%$29.02 - $32.4
($30.05)
$ 31.14%Reduce -70.71%2,303,762
PFEJohn Hussman 2014-06-30 Sold Out -0.04%$29.02 - $32.4
($30.05)
$ 31.14%Sold Out0
PFEHOTCHKIS & WILEY 2014-06-30 Reduce-0.01%$29.02 - $32.4
($30.05)
$ 31.14%Reduce -33.68%128,800
PFEIrving Kahn 2014-03-31 Add0.98%$29.66 - $32.75
($31.36)
$ 31.1-1%Add 11.22%2,112,819
PFEJoel Greenblatt 2014-03-31 Add0.38%$29.66 - $32.75
($31.39)
$ 31.1-1%Add 356.54%1,014,808
PFEJohn Hussman 2014-03-31 Buy 0.04%$29.66 - $32.75
($31.36)
$ 31.1-1%New holding, 17000 sh.17,000
PFEVanguard Health Care Fund 2014-03-31 Reduce-0.48%$29.66 - $32.75
($31.36)
$ 31.1-1%Reduce -40.13%7,276,622
PFENWQ Managers 2014-03-31 Reduce-0.39%$29.66 - $32.75
($31.39)
$ 31.1-1%Reduce -13.6%9,231,207
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PFE David Dreman 2014-09-3015,04000.04+10.47%
PFE John Keeley 2014-09-3097,33900.06+8.35%
PFE Brian Rogers 2014-09-3012,737,1150.21.4+3.66%
PFE Charles Brandes 2014-09-306,257,0900.12.5+2.99%
PFE James Barrow 2014-09-3062,170,8810.982.5+2.76%
PFE Ken Fisher 2014-09-3031,702,4950.52+0.7%
PFE Vanguard Health Care Fund 2014-09-3014,934,0220.241.1
PFE Robert Bruce 2014-09-30452,0000.013.7
PFE Prem Watsa 2014-09-30235,00000.47
PFE Ruane Cunniff 2014-09-3010,96700-0.18%
PFE NWQ Managers 2014-09-306,338,4580.12-0.39%
PFE Dodge & Cox 2014-09-3047,604,9800.751.3-2.65%
PFE Ronald Muhlenkamp 2014-09-3039,49900.21-3.71%
PFE Irving Kahn 2014-09-301,985,1610.039.5-6.56%
PFE Joel Greenblatt 2014-09-301,622,0920.030.48-6.85%
PFE Mario Gabelli 2014-09-301,023,5810.020.16-7.29%
PFE Ray Dalio 2014-09-30295,10800.07-24.91%
PFE Michael Price 2014-09-3047,10000.17-56.02%
PFE Jean-Marie Eveillard 2014-09-30135,66100.01-94.11%
PFE HOTCHKIS & WILEY 2014-09-30000Sold Out
PFE Mark Hillman 2013-12-3123,98201.1
Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HILL CHARLES HExecutive Vice President 2014-11-10Sell8,285$30.183.05view
DAMELIO FRANK AExecutive Vice President 2014-11-07Sell0$29.784.43view
YOUNG JOHN DGroup President 2014-11-07Sell21,600$29.894.05view
READ IAN CChairman & CEO 2014-10-30Sell67,500$29.764.5view
MADDALUNA ANTHONY JExecutive Vice President 2014-10-29Sell2,425$29.565.21view
OLSON LAURIE JExecutive Vice President 2014-06-12Sell36,275$29.535.32view
Germano Geno JGroup President 2014-06-02Sell30,000$29.684.78view
YOUNG JOHN DGroup President 2014-03-17Sell9,000$31.38-0.89view
PFIZER INC10% Owner 2014-03-12Buy272,727$11182.73view
CANGIALOSI LORETTA VSr. Vice President, Controller 2014-03-04Sell102,943$32.05-2.96view

Press Releases about PFE :

Quarterly/Annual Reports about PFE:

    News about PFE:

    Articles On GuruFocus.com
    Guru Ken Fisher’s Top Five Quarterly Stocks Nov 16 2014 
    Ackman’s Pershing Group Buys Stake in Zoetis Nov 13 2014 
    Activist Bill Ackman Buys Big Stake In Animal Healthcare Company Zoetis Nov 12 2014 
    The Importance of Capital Intensity and Thoughts From Einhorn Oct 31 2014 
    Johnson & Johnson Fairly Valued – I Will Bet on It Oct 30 2014 
    My 5 Favorite Stocks With Dividend Growth Of The Week Oct 27 2014 
    Guru Stocks at 52-Week Lows: GOOG, PFE, UN, E, MTU Oct 20 2014 
    10 Stocks With The Highest Share Buyback Volume In 2014 Oct 03 2014 
    A Few Reasons Why AbbVie's Momentum Will Continue Sep 25 2014 
    The Dogs of the Dow Lost Some Steam In The August Heat, But Maintained Their Lead Sep 16 2014 


    More From Other Websites
    As Deadline Passes, Will AstraZeneca plc Attract A New Bid From Pfizer Inc? Nov 26 2014
    Pfizer to join forces with AstraZeneca? Nov 26 2014
    BUZZ-AstraZeneca: Pfizer may turn M&A sights on Mylan -Jefferies Nov 26 2014
    Pfizer to renew pursuit of AstraZeneca? Nov 26 2014
    AstraZeneca comes into focus as Pfizer's cooling-off period ends Nov 25 2014
    FTSE rally pulls back from two-month high as Petrofac slump weighs Nov 24 2014
    Buying Glaxo's Biotech Stock Throwbacks Proves Profitable Nov 24 2014
    Motley Fool: Pundits pandering your wealth away Nov 22 2014
    Do The IMPROVE-IT Results Offer Promise For Anacetrapib, Another Merck Heart Drug? Nov 21 2014
    New data fuels doctors' demands to rewrite U.S. heart guidelines Nov 21 2014
    Merck KGaA Ties Up with Pfizer on Immuno-oncology Deal Nov 18 2014
    AstraZeneca fleshes out standalone strategy Nov 18 2014
    TRUMENBA® (Meningococcal Group B Vaccine) is Now Available Nov 18 2014
    AstraZeneca’s Soriot Asks for Patience as Pfizer Return Looms Nov 18 2014
    Neil Woodford: there's a 50/50 chance Pfizer will come back for AstraZeneca Nov 18 2014
    AstraZeneca trumpets solo strength in cancer drugs, snubbing Pfizer Nov 18 2014
    AstraZeneca trumpets solo strength in cancer drugs, snubbing Pfizer Nov 18 2014
    AstraZeneca trumpets solo strength in cancer drugs, snubbing Pfizer Nov 18 2014
    TRUMENBA® (Meningococcal Group B Vaccine) is Now Available Nov 18 2014
    Neil Woodford says belief in independent AstraZeneca 'even stronger' Nov 18 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    SEENSCO
    ReplySEENSCO - 5 months ago
    PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK